期刊文献+

血小板功能检测的常用方法及容易忽略的影响因素 被引量:10

Common methods of platelet function testing and factors easily overlooked
暂未订购
导出
摘要 目前,血小板功能检测是评价抗血小板治疗效果的主要工具,但能否根据其指导个体化的抗血小板治疗尚存争议。同时,研究新的、更精准的血小板功能检测方法具有十分重要的意义。本文就当前常用的和正在研究中的血小板功能检测方法,及临床上容易被忽略的影响因素做一综述。 Platelet function test is the main tool to evaluate the effect of antiplatelet therapy.However,whether individual antiplatelet therapy can be guided by platelet function testing is still controversial.At the same time,it is of great significance to study newer and more accurate methods for the detection of platelet function.This review summarized the current commonly used and under-researched methods of platelet function test,and the factors easy to be ignored clinically.
作者 贾媛 白世茹 李如意 杜荣品 Jia Yuan;Bai Shiru;Li Ruyi;Du Rongpin(Department of Cardiology, Hebei General Hospital, Shijiazhuang 050051, China)
出处 《中国心血管杂志》 2020年第2期197-200,共4页 Chinese Journal of Cardiovascular Medicine
关键词 血小板功能试验 血栓形成 血小板聚集抑制剂 影响因素 Platelet function tests Thrombosis Platelet aggregation inhibitors Influence factors
  • 相关文献

参考文献5

二级参考文献49

  • 1Gianetti J, Parri MS, Sbrana S, et al. Platelet activation predicts recurrent ischemic events after percutaneous coro- nary angioplasty: a 6 months prospective study. Thromb Res 2006; 118: 487-493.
  • 2Geisler T, Langer H, Wydymus M, et al. Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantation. Eur Heart J 2006; 27: 2420-2425.
  • 3Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syn- dromes without ST-segment elevation, N Engl J Med 2001 345: 494-502.
  • 4Steinhubl SR, Berger PB, Mann JT, et al. Early and sus- tained dual oral antiplatelet therapy following percutane- ous coronary intervention: a randomized controlled trial. JAMA 2002; 288:2411-2420.
  • 5Budaj A, Brieger D, Steg PG, et al. Global patterns of use of antithrombotic and antiplatelet therapies in patients with acute coronary syndromes: insights from the Global Reg- istry of Acute Coronary Events (GRACE). Am Heart J 2003; 146: 999-1006.
  • 6Lee SW, Park SW, Hong MK, et al. Triple versus dual antiplatelet therapy after coronary stenting: impact on stent thrombosis. JAm Coll Cardio12005; 46: 1833-1837.
  • 7Patti G, Colonna G, Pasceri V, et al. Randomized trial of high loading dose of clopidogrel for reduction of peripro- cedural myocardial infarction in patients undergoing coro- nary intervention: results from the ARMYDA-2 (Anti- platelet therapy for reduction of myocardial damage during angioplasty) study. Circulation 2005; 111: 2099-2106.
  • 8Cuisset T, Frere C, Quilici J, et al. High post-treatment platelet reactivity identified low-responders to dual anti- platelet therapy at increased risk of recurrent cardiovascu- lar events after stenting for acute coronary syndrome. J Thromb Haemost 2006; 4: 542-549.
  • 9Lev EI, Patel RT, Maresh KJ, et al. Aspirin and clopido- grel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance. J Am Coll Cardio12006; 47: 27-33.
  • 10Snoep JD, Hovens MM, Eikenboom JC, et al. Clopidogrel nonresponsiveness in patients undergoing percutaneous coronary intervention with stenting: a systematic review and meta-analysis. Am Heart J 2007; 154:221-231.

共引文献23

同被引文献105

引证文献10

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部